Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain

Author/s: 
McDonagh, M. S., Wagner, J., Ahmed, A. Y., Fu, R., Morasco, B., Kansagara, D., Chou, R.
Date Added: 
October 13, 2022
Journal/Publication: 
Agency for Healthcare Research and Quality
Publisher: 
US Department of Health and Human Services
Publication Date: 
October 6, 2022
Type: 
Meta-analyses, Reviews, and Guidelines
Format: 
Article
DOI (1): 
10.23970/AHRQEPCCER250
PMID (1): 
34882379

RPR Commentary

An updated version of a systematic review previously posted to RPR Exchange. James W. Mold, MD, MPH

Abstract

In an effort to address the opioid epidemic, a prominent goal of current research is to identify alternative treatments with equal or better benefits for pain while avoiding potential unintended consequences that could result in harms.

This 'living' systematic review assesses the effectiveness and harms of cannabis and other plant-based treatments for chronic pain conditions. For the purposes of this review, plant-based compounds (PBCs) included are those that are similar to opioids in effect and that have the potential for addiction, misuse, and serious adverse effects; other PBCs such as herbal treatments are not included. The intended audience includes policy and decision makers, funders and researchers of treatments for chronic pain, and clinicians who treat chronic pain.

The report will be updated on a quarterly basis.

Text Availability

Free full text